Choosing a Surgical Robot: da Vinci vs. Hugo vs. Ottava
- Jul 27
- 4 min read
Updated: 5 hours ago
Choosing a surgical robot is no longer a one-company decision.
For years, Intuitive's da Vinci platform dominated robotic soft tissue surgery. Today, Medtronic's Hugo and Johnson & Johnson's Ottava offer hospitals alternative approaches, each built around different priorities.
All three platforms allow surgeons to perform minimally invasive procedures with robotic assistance.
None performs surgery autonomously.
The differences lie in design, workflow, clinical experience, and software.
Clinical experience
Clinical experience matters.
Hospitals want systems supported by years of published evidence, large numbers of procedures, and established training pathways.
da Vinci has the longest track record by a wide margin. Millions of procedures have been performed worldwide using the da Vinci family of systems across multiple surgical specialties.
Hugo entered the market much later but continues expanding internationally. Clinical experience is growing steadily, particularly in urology, with additional specialties being added over time.
Ottava is the newest platform. Early clinical experience is limited compared with its competitors, and broader adoption will depend on future regulatory approvals and real-world outcomes.
If clinical history is the priority, da Vinci remains the benchmark.
Operating room footprint
Not every operating room has unlimited space.
The three systems approach OR design differently.
da Vinci uses an integrated patient cart that is already familiar to hospitals performing robotic surgery.
Hugo separates each robotic arm onto its own mobile cart. Arms can be positioned independently around the patient and moved between operating rooms as needed.
Ottava takes a different approach entirely.
Its robotic arms are built directly into the operating table and retract underneath when not in use. This reduces equipment surrounding the patient and creates a more open operating room.
Hospitals with limited OR space may find Hugo and Ottava particularly attractive.
Console design
The three systems take different approaches to the surgeon console.
da Vinci 5 uses an immersive console, with the surgeon viewing the procedure through a dedicated 3D display and operating from hand controls.
Ottava uses the Apollo Console, designed around an upright surgeon position and access to the wider operating environment.
Hugo takes the most explicitly open approach. Its open console provides 3D HD visualization while maintaining a direct sightline to the bedside team. Medtronic specifically positions this as a way to preserve situational awareness and facilitate communication and training.
Haptic feedback
One of robotic surgery's biggest limitations has always been the loss of touch.
Surgeons can see tissue clearly but cannot naturally feel how much force they are applying.
da Vinci 5 addresses this with Force Feedback.
The system allows surgeons to feel resistance through the controls while also displaying force information on screen.
Neither Hugo nor Ottava currently offers equivalent clinical force feedback.
As robotic surgery continues to evolve, restoring tactile sensation is likely to become an increasingly important area of competition.
AI ecosystem
Modern robotic platforms are becoming software platforms as much as hardware platforms.
Intuitive is expanding the da Vinci ecosystem with increasing computing power and AI-enabled software designed to support workflow, data analysis, and future intelligent assistance.
Medtronic has built Hugo around the Touch Surgery ecosystem.
This allows AI applications such as computer vision, workflow analysis, and real-time surgical guidance to run on top of the robotic platform.
Johnson & Johnson has positioned Ottava for future software integration, although its AI ecosystem remains less mature than those of its competitors.
Increasingly, the software running on a robot may become as important as the robot itself.
Approved procedures
Each platform currently supports different clinical indications.
da Vinci offers the broadest range of approved procedures, including urology, gynecology, colorectal surgery, thoracic surgery, general surgery, and selected cardiac procedures.
Hugo initially focused on urology and continues expanding into additional specialties.
Ottava launched with approval for selected upper abdominal general surgical procedures and is expected to broaden its indications over time.
Hospitals should evaluate each platform based on the procedures they perform most frequently rather than the total number of approvals.
Learning curve
Every robotic platform requires training.
Surgeons already familiar with robotic surgery generally adapt more quickly than those learning robotic techniques for the first time.
Because da Vinci has been used for many years, it offers the largest network of experienced mentors, training programs, and educational resources.
Hugo and Ottava introduce different console layouts and workflows, requiring additional training even for experienced robotic surgeons.
The best platform is often the one a hospital can support with structured education and consistent case volume.
Cost considerations
Purchasing a robotic platform involves more than the initial system.
Hospitals also evaluate maintenance, disposable instruments, service agreements, staff training, operating room efficiency, and long-term upgrade pathways.
Exact costs vary widely between institutions and purchasing agreements.
For many hospitals, the decision is based on overall value rather than purchase price alone.
Factors such as procedure volume, specialty mix, and future software capabilities often influence the final decision as much as hardware.
Which hospitals suit each platform?
da Vinci
Best for hospitals seeking the most established robotic platform with extensive clinical evidence and broad procedural coverage.
Hugo
Best for hospitals prioritizing operating room flexibility, modular design, and integration with Medtronic's growing AI software ecosystem.
Ottava
Best for hospitals interested in a compact operating room layout and an integrated table-based robotic platform.
Comparison at a glance
Feature | da Vinci 5 | Hugo | Ottava |
Clinical experience | Extensive | Growing | Early stage |
OR design | Integrated patient cart | Modular robotic arm carts | Arms integrated into operating table |
Console | Closed immersive | Open | Closed, upright |
Haptic feedback | Yes | No | No |
AI ecosystem | Expanding | Touch Surgery platform | Early stage |
Procedure coverage | Broadest | Expanding | Limited but growing |
Main strength | Proven platform | Flexibility | Integrated OR design |
The bottom line
Each platform reflects a different philosophy.
da Vinci builds on decades of clinical experience and now adds force feedback and increasing AI capability.
Hugo emphasizes flexibility through modular hardware and software integration.
Ottava rethinks the physical design of robotic surgery by integrating the robot into the operating table.
None of these systems performs autonomous surgery.
All remain surgeon-controlled robotic platforms.
Choosing between them depends less on which robot is "best" and more on which platform best fits a hospital's clinical practice, operating rooms, and long-term strategy.
Key takeaways
da Vinci has the longest clinical track record and the broadest range of approved procedures.
Hugo focuses on modular operating room design and AI software integration.
Ottava introduces a table-integrated robotic architecture with a smaller operating room footprint.
The three platforms differ primarily in workflow, ergonomics, and software rather than autonomy.
The best platform depends on a hospital's specialties, infrastructure, and long-term goals.
Comments